2016: "To develop a novel platform technologies for antibodies or vaccines to reduce HIV acquisition in developing countries"
2019: "To assess the feasibility of mRNA technology to deliver antibody combinations in selected neonates in low resource settings in order to reduce the impact of neonatal sepsis in this vulnerable population"
Moderna:
https://www.gatesfoundation.org/about/committed-grants?q=mod...
2016: "To develop a novel platform technologies for antibodies or vaccines to reduce HIV acquisition in developing countries"
2019: "To assess the feasibility of mRNA technology to deliver antibody combinations in selected neonates in low resource settings in order to reduce the impact of neonatal sepsis in this vulnerable population"
BioNTech:
https://www.gatesfoundation.org/about/committed-grants?q=bio...
2020: "To development of a COVID-19 therapeutic approach"
There was also a 2019 investment in BioNTech to develop an HIV vaccine.